← FDA DRUG APPROVALS

FDA ANDA · ANDA078345

PREDNISOLONE SODIUM PHOSPHATE

Sponsor: AMNEAL PHARMS

APPLICATION
ANDA078345
TYPE
ANDA
ORIGINAL APPROVAL
2009-03-10
LATEST ACTION
2014-06-13
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

PREDNISOLONE SODIUM PHOSPHATEDiscontinued
PREDNISOLONE SODIUM PHOSPHATE EQ 15MG BASE/5ML · SOLUTION · ORAL

Approval history

2014-06-13Manufacturing (CMC) · Supplement 6AP
2009-03-10OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →